Expression of Glucocorticoid Receptor Beta in Bladder Cancer and Its Clinicopathological Significance: A Novel Diagnostic Marker to Predict Progression and Recurrence of Cancer
These findings suggest that GRβ may serve as a potential biomarker for predicting the progression and recurrence of bladder cancer.
Authors
- Tomonori Habuchi (ORCID: https://orcid.org/0000-0003-0998-4432)
- M. Oikawa (ORCID: https://orcid.org/0000-0001-6832-3242)
- Kazuyuki Numakura (ORCID: https://orcid.org/0000-0002-5899-1738)
- Yasuhiro Kaiho (ORCID: https://orcid.org/0000-0003-3793-8214)
- Masashi Kato (ORCID: https://orcid.org/0000-0002-3515-5526)
- Yasuhiro Nakamura (ORCID: https://orcid.org/0000-0003-2167-9182)
- Shintaro Narita (ORCID: https://orcid.org/0000-0003-2988-1860)
- Shuko Hata
- Kento Morozumi (ORCID: https://orcid.org/0000-0002-9651-2371)
- Haruka Saito (ORCID: https://orcid.org/0000-0002-0482-8126)
- Takashi Kukimoto
- Makoto Sato (ORCID: https://orcid.org/0000-0001-7683-8078)
- Hiroki Shimada (ORCID: https://orcid.org/0000-0001-9910-4755)
- Hiroki Kusumoto
- Tomoaki Ogata
Institutions
- Akita University (JP)
- Tohoku Medical and Pharmaceutical University Hospital (JP)
- Tohoku Medical and Pharmaceutical University (JP)
Publication Details
- Journal
- International Journal of Urology
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1111/iju.70254
- Primary Topic
- Estrogen and related hormone effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00